ESOPMay 22, 2026, 04:02 PM
Avalo Therapeutics Grants 34,000 Stock Options to New Employee
AI Summary
Avalo Therapeutics, Inc. announced it granted an inducement award consisting of an option to purchase 34,000 shares of its common stock to one new employee. The award, approved by the Compensation Committee, was granted on May 21, 2026, with an exercise price of $16.60 per share. The options will vest 25% on the one-year anniversary of the employee's start date, with the balance vesting monthly over 36 months, subject to continued service.
Key Highlights
- Avalo Therapeutics granted an option to purchase 34,000 shares of common stock.
- The award was granted to one new employee as an inducement.
- The option grant date was May 21, 2026.
- The exercise price is $16.60 per share, equal to the closing price on the grant date.
- The option vests 25% on the one-year anniversary of employment.
- The remaining shares vest monthly over 36 months thereafter.
Price Impact
More from AVTX